2006 Annual Meeting | Dementia Evaluation in the Office

Date Monday 04/03/06

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Zoe Arvanitakis, MD, MS, FAAN

Topic(s) Practice Management

Learning Objectives Upon Completion:
Participants should be able to recognize the key clinical features of and to implement a management plan for the most common degenerative dementias, including Alzheimer's disease, Lewy body disease, and frontotemporal dementia, as well as the most common nondegenerative dementias and vascular dementia; and be able to distinguish among older persons with normal cognitive function, those with mild cognitive impairment, and those with Alzheimer's disease; and acquire an approach to the evaluation of atypical forms of dementia.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Advanced

Recommended Audience Practitioner, Fellow, Resident, Nurse

Event Timeline
06:45 AM - 07:15 AM		Alzheimer's Disease and Mild Cognitive Impairment John C. Morris, MD, FAAN
06:45 AM - 08:30 AM		Breakfast
07:15 AM - 07:45 AM		Vascular Dementia and Lewy Body Disease Julie A. Schneider, MD, MS
07:45 AM - 08:15 AM		Frontotemporal Dementia and Evaluation of Atypical Dementias Zoe Arvanitakis, MD, MS, FAAN
08:15 AM - 08:30 AM		Discussion

Faculty Disclosures
Zoe Arvanitakis, MD, MS, FAAN	Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc.. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Dementia. Dr. Arvanitakis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for a private legal firm representing a governement entity. The institution of Dr. Arvanitakis has received research support from National Institutes of Health (NIH). The institution of Dr. Arvanitakis has received research support from Amylyx. The institution of Dr. Arvanitakis has received research support from Lilly. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with The National Institutes of Health and California State (California Institute for Regenerative Medicine or CIRM). Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant and Educator with Summus Global, Inc.
John C. Morris, MD, FAAN	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Julie A. Schneider, MD, MS	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for apellis. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for National Hockey League. The institution of Dr. Schneider has received research support from NIH. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a scientific advisor with Fondation Alzheimer, France.

��ɫ��

��ɫ��